We anticipate a high level of demand for our products, as they will allow labs to save money, time and

Murrieta Genomics was recently named as a “company to watch” by The Healthcare Insights, a medical publication that discusses developments

Murrieta Genomics has announced that its wholly owned subsidiary, SimplSeq Inc., has filed a new patent application for simplified sample

Murrieta Genomics has partnered with Life Science Nation (LSN) and the RESI (Redefining Early Stage Investments) Conference to offer startup

We anticipate a high level of demand for our products, as they will allow labs to save money, time and

Murrieta Genomics was recently named as a “company to watch” by The Healthcare Insights, a medical publication that discusses developments

Murrieta Genomics has announced that its wholly owned subsidiary, SimplSeq Inc., has filed a new patent application for simplified sample

Murrieta Genomics has partnered with Life Science Nation (LSN) and the RESI (Redefining Early Stage Investments) Conference to offer startup

The RuleOut team has created a novel approach that can exponentially increase COVID-19 testing capacity.

Life Science Nation provides an incredibly important service to early stage life science companies by connecting them with products, services

John Powers, President of Murrieta Genomics and CEO of SimplSeq, our wholly owned subsidiary, was interviewed recently on Beyone with

Murrieta Genomics start-up TX Genetic Research was recently awarded second place in a national competition held by Golden Helix,